In 2019, analgesics registered double-digit current value growth, with further progress expected over the forecast period. However, rising prices was the main factor boosting value sales, as volume sales declined in most categories.
Adult dipyrone and adult aspirin also performed well in current value terms in 2019, with the latter benefiting from increasing stress levels and urban lifestyles. Topical analgesics/anaesthetic also saw strong growth, thanks to increasing participation in sports, especially amongst men.
The increasing number of chemists/pharmacies across the country, in tandem with growth in the population, is ensuring continued demand for analgesics in Uzbekistan. The government has paid attention to supporting socially vulnerable segments of the population.
Despite favourable conditions for domestic companies, foreign multinationals continued to account for the majority of value sales within analgesics in 2019. GSK Consumer Healthcare took the lead from Radiks in 2019, with Radiks in second and Taisho Pharmaceutical Holdings entering in third, after taking over the leading Efferalgan brand from Bristol-Myers Squibb in 2019.
Despite the dominance of foreign players within analgesics, domestic producers are expected to strengthen their positions in the forecast period. Remedy Group, Uzkhimpharm and Radiks already offer various types of analgesics, which account for a reasonable share of retail value sales, and these are the largest Uzbekistani pharmaceutical companies in this category.
Overall, the affordable prices of domestic producers may ultimately be to their benefit over foreign alternatives, given the ongoing price-sensitivity amongst consumers in the country. Nevertheless, the majority of people still currently trust long-standing and well-known foreign brands, especially as they are frequently advertised on Russian TV channels, which are regularly watched in Uzbekistan.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Uzbekistan with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Uzbekistan market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.